Brief: Interpace Diagnostics Group Says Is Eligible For An Additional 180-Day Period To Regain Compliance

Interpace Biosciences

17/10/2019 22:47

Oct 17 (Reuters) - Interpace Diagnostics Group Inc  IDXG.O :
    * INTERPACE DIAGNOSTICS GROUP INC - NASDAQ HAS DETERMINED
THAT
COMPANY IS ELIGIBLE FOR AN ADDITIONAL 180-DAY PERIOD TO REGAIN
COMPLIANCE

Source text: [https://bit.ly/2OWmeEd]
Further company coverage:  IDXG.O 

 (Reuters.Briefs@thomsonreuters.com)